Going beyond manufacturers' limitations is not in the best interest of our patients
- PMID: 24779128
- PMCID: PMC4557503
Going beyond manufacturers' limitations is not in the best interest of our patients
Comment in
-
Response to letter "Going beyond manufacturers' limitations is not in the best interests of our patients" by Gerard J. Myers.J Extra Corpor Technol. 2014 Mar;46(1):103-4. J Extra Corpor Technol. 2014. PMID: 24779129 No abstract available.
Comment on
-
Prescriptive patient extracorporeal circuit and oxygenator sizing reduces hemodilution and allogeneic blood product transfusion during adult cardiac surgery.J Extra Corpor Technol. 2013 Sep;45(3):167-72. J Extra Corpor Technol. 2013. PMID: 24303598 Free PMC article.
Similar articles
-
Response to letter "Going beyond manufacturers' limitations is not in the best interests of our patients" by Gerard J. Myers.J Extra Corpor Technol. 2014 Mar;46(1):103-4. J Extra Corpor Technol. 2014. PMID: 24779129 No abstract available.
-
Extracorporeal shunt: a theoretical approach to the prevention of arterial hyperoxia and the reduction of gaseous emboli during cardiopulmonary bypass.Anesth Analg. 1996 Mar;82(3):672-3. doi: 10.1097/00000539-199603000-00052. Anesth Analg. 1996. PMID: 8623987 No abstract available.
-
Cardiopulmonary bypass/extracorporeal membrane oxygenation/left heart bypass: indications, techniques, and complications.Surg Clin North Am. 2009 Aug;89(4):781-96, vii-viii. doi: 10.1016/j.suc.2009.05.006. Surg Clin North Am. 2009. PMID: 19782837 Review.
-
Prescriptive patient extracorporeal circuit and oxygenator sizing reduces hemodilution and allogeneic blood product transfusion during adult cardiac surgery.J Extra Corpor Technol. 2013 Sep;45(3):167-72. J Extra Corpor Technol. 2013. PMID: 24303598 Free PMC article.
-
Pediatric cardiopulmonary bypass devices: trends in device use for cardiopulmonary bypass and postcardiotomy support.ASAIO J. 2005 Sep-Oct;51(5):525-9. doi: 10.1097/01.mat.0000180399.24938.a5. ASAIO J. 2005. PMID: 16322711 Review.
References
-
- McIlroy DR, Kharasch ED.. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003;96:1572–1577. - PubMed
-
- Straub D, Boudreau MC, Gefen D.. Validation guidelines for IS Positivist research. Comm Assn Info Syst. 2004;13:380–427.
-
- Myers GJ.. Predictive Hemodilution—The Principles and Practice of Hemodilution during Cardiac Surgery. Mirandola, Italy: Sorin Group Perfusion Books; 2013.
-
- Klepinski R: Off-label use of medical devices in the USA. Journal Med Device Reg. 2009;6:8–19.
-
- U.S. Department of Health and Human Services (FDA). Off-label and investigational use of marketed drugs, biologics, and medical devices. 2011. Available at: www.fda.gov/RegulatoryInformation/Guidances/ucm126486.htm.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources